RAMM Pharma Corp. RAMM

Company Overview

RAMM Pharma Corp. is a Canadian life sciences and pharmaceutical company focused on cannabinoid-based pharmaceuticals, nutraceuticals, and cosmetic products. The company operates primarily in the regulated medical cannabis and cannabinoid therapeutics sector, with activities spanning pharmaceutical formulation, cultivation, extraction, clinical research, and international product commercialization. RAMM is publicly traded on the Canadian Securities Exchange under the ticker RAMM and has concentrated much of its operational activity in Latin America, particularly Uruguay and Brazil.

The company’s primary revenue drivers include the production and export of pharmaceutical-grade cannabinoid ingredients, medical cannabis products, and related wellness formulations. Through its subsidiaries, RAMM has developed vertically integrated capabilities that include cannabis cultivation, extraction, formulation development, and regulatory compliance for export markets. The company evolved from a broader cannabis-focused investment and operating model into a pharmaceutical-oriented cannabinoid business emphasizing international medical markets, especially jurisdictions with evolving cannabinoid regulatory frameworks and limited domestic production infrastructure.